Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
《癌症》（ISSN 2072-6694）是一本国际同行评审的开放获取肿瘤学杂志。它发表评论、定期研究论文和简短通讯。我们的目的是鼓励科学家尽可能详细地发表他们的实验和理论结果。论文的长度没有限制。必须提供完整的实验细节，以便重现结果。
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
来源期刊：CancersDOI：10.3390/cancers11091334
Integrins, CAFs and Mechanical Forces in the Progression of Cancer
来源期刊：CancersDOI：10.3390/cancers11050721
Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades
来源期刊：CancersDOI：10.3390/cancers11060813
The Radiobiological Effects of Proton Beam Therapy: Impact on DNA Damage and Repair
来源期刊：CancersDOI：10.3390/cancers11070946
Human Cachexia Induces Changes in Mitochondria, Autophagy and Apoptosis in the Skeletal Muscle
来源期刊：CancersDOI：10.3390/cancers11091264
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
来源期刊：CancersDOI：10.3390/cancers11070995
MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer
来源期刊：CancersDOI：10.3390/cancers11030378
The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis
来源期刊：CancersDOI：10.3390/cancers11060832
Pretreatment Cancer-Related Cognitive Impairment—Mechanisms and Outlook
来源期刊：CancersDOI：10.3390/cancers11050687
Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
来源期刊：CancersDOI：10.3390/cancers11070954
Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer
来源期刊：CancersDOI：10.3390/cancers11060805
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project
来源期刊：CancersDOI：10.3390/cancers11081061
Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma
来源期刊：CancersDOI：10.3390/cancers11070986
Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?
来源期刊：CancersDOI：10.3390/cancers11091269
Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications
来源期刊：CancersDOI：10.3390/cancers11111802
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
来源期刊：CancersDOI：10.3390/cancers11070981
New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma
来源期刊：CancersDOI：10.3390/cancers11050694
Wnt Signaling Pathways in Keratinocyte Carcinomas
来源期刊：CancersDOI：10.3390/cancers11091216
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome
来源期刊：CancersDOI：10.3390/cancers11091219
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials
来源期刊：CancersDOI：10.3390/cancers11111661
The Chalcone Lonchocarpin Inhibits Wnt/β-Catenin Signaling and Suppresses Colorectal Cancer Proliferation
来源期刊：CancersDOI：10.3390/cancers11121968
Type 1 Sodium Calcium Exchanger Forms a Complex with Carbonic Anhydrase IX and Via Reverse Mode Activity Contributes to pH Control in Hypoxic Tumors
来源期刊：CancersDOI：10.3390/cancers11081139
Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029
来源期刊：CancersDOI：10.3390/cancers11020179
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
来源期刊：CancersDOI：10.3390/cancers11121940
HOX Genes in High Grade Ovarian Cancer
来源期刊：CancersDOI：10.3390/cancers11081107
Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis
来源期刊：CancersDOI：10.3390/cancers11070970
Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
来源期刊：CancersDOI：10.3390/cancers11050648
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells
来源期刊：CancersDOI：10.3390/cancers11081129
3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms
来源期刊：CancersDOI：10.3390/cancers11020130
Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers
来源期刊：CancersDOI：10.3390/cancers11010103
Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
来源期刊：CancersDOI：10.3390/cancers11050653
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
来源期刊：CancersDOI：10.3390/cancers11060802
The History of Armand Trousseau and Cancer-Associated Thrombosis
来源期刊：CancersDOI：10.3390/cancers11020158
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer
来源期刊：CancersDOI：10.3390/cancers12010104
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas
来源期刊：CancersDOI：10.3390/cancers11091238
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)
来源期刊：CancersDOI：10.3390/cancers11081137
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer
来源期刊：CancersDOI：10.3390/cancers11091372
Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases
来源期刊：CancersDOI：10.3390/cancers11060811
In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
来源期刊：CancersDOI：10.3390/cancers11101446
CNOT2 Is Critically Involved in Atorvastatin Induced Apoptotic and Autophagic Cell Death in Non-Small Cell Lung Cancers
来源期刊：CancersDOI：10.3390/cancers11101470
FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma
来源期刊：CancersDOI：10.3390/cancers11101427
Long-Term Visual Outcomes for Small Uveal Melanoma Staged T1 Treated by Proton Beam Radiotherapy
来源期刊：CancersDOI：10.3390/cancers11081047
Discovering Rare Genes Contributing to Cancer Stemness and Invasive Potential by GBM Single-Cell Transcriptional Analysis
来源期刊：CancersDOI：10.3390/cancers11122025
Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients
来源期刊：CancersDOI：10.3390/cancers11040464
YC-1 Antagonizes Wnt/β-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma
来源期刊：CancersDOI：10.3390/cancers11050661
Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma
来源期刊：CancersDOI：10.3390/cancers11111672
Rectum Dose Constraints for Carbon Ion Therapy: Relative Biological Effectiveness Model Dependence in Relation to Clinical Outcomes
来源期刊：CancersDOI：10.3390/cancers12010046
The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300
来源期刊：CancersDOI：10.3390/cancers11070962
GLUL Ablation Can Confer Drug Resistance to Cancer Cells via a Malate-Aspartate Shuttle-Mediated Mechanism
来源期刊：CancersDOI：10.3390/cancers11121945
Do We Really Need Another Special Issue on NF-κB in Cancer and Inflammation?
来源期刊：CancersDOI：10.3390/cancers11121978
